PharmEasy raises $350 Mn in pre-IPO round at $5.6 Bn valuation; founders receive new ESOPs


Content Team
Image Credit: nextbigbrand

IPO-bound PharmEasy which is set to file its draft red herring prospectus (DRHP) this month has scooped up $350 Mn in a primary as well as secondary round. After the primary round worth $204 Mn and secondary sale of shares worth $150 Mn, the startup is eyeing an IPO by March 2022.